Attached files
| file | filename |
|---|---|
| 10-K/A - AMENDMENT TO ANNUAL REPORT FORM 10-K - CardioGenics Holdings Inc. | v308630_10ka.htm |
| EX-32.1 - EXHIBIT 32.1 - CardioGenics Holdings Inc. | v308630_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - CardioGenics Holdings Inc. | v308630_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - CardioGenics Holdings Inc. | v308630_ex31-2.htm |
| EX-23.3 - EXHIBIT 23.3 - CardioGenics Holdings Inc. | v308630_ex23-3.htm |
| EX-23.2 - EXHIBIT 23.2 - CardioGenics Holdings Inc. | v308630_ex23-2.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Our report on our audit of the consolidated financial statements of CardioGenics Holdings, Inc. as of October 31, 2010 and for the year then ended and on the consolidated statements of operations, changes in equity (deficiency) and cash flows for the period from November 20, 1997 (date of inception) to October 31, 2010, which expressed an unqualified opinion on those financial statements and contains an explanatory paragraph relating to the Company’s ability to continue as a going concern, included in this Annual Report on Form 10-K/A Amendment No. 2 for the year ended October 31, 2011, is dated January 31, 2011. We consent to the incorporation by reference of our report in the registration statement previously filed by the Company with the Securities and Exchange Commission pursuant to the Securities Act of 1933: on Form S-8 with SEC file No. 333-137162.
/s/ J.H. Cohn LLP
Roseland, New Jersey
April 13, 2012